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Abstract
 
Plasma membrane microdomains containing sphingolipids and cholesterol (lipid rafts) are en-
riched in signaling molecules. The cross-linking of certain types of cell surface receptors ini-
tiates the redistribution of these lipid rafts, resulting in the formation of signaling complexes.
However, little is known about the regulation of the initial raft redistribution and whether neg-
ative regulatory signaling pathways target this phase of cellular activation. We used natural killer
(NK) cells as a model to investigate the regulation of raft redistribution, as both positive and neg-
ative signals have been implicated in the development of their cellular function. Here we show
that after NK cells form conjugates with sensitive tumor cells, rafts become polarized to the site of
target recognition. This redistribution of lipid rafts requires the activation of both Src and Syk
family protein tyrosine kinases. In contrast, engagement of major histocompatibility complex
(MHC)-recognizing killer cell inhibitory receptors (KIRs) on NK cells by resistant, MHC-bear-
ing tumor targets blocks raft redistribution. This inhibition is dependent on the catalytic activity
of KIR-associated SHP-1, a Src homology 2 (SH2) domain containing tyrosine phosphatase.
These results suggest that the influence of integrated positive and negative signals on raft redistri-
bution critically influences the development of cell-mediated cytotoxicity.
Key words: natural killer cell • signal transduction • cytotoxicity, immunologic • tyrosine 
kinase • tyrosine phosphatase
 
Introduction
 
A major portion of eukaryotic membranes is in a fluid, un-
ordered state due to the low melting temperatures of glyc-
erolipids. However, within the glycerolipid environment
there are “islands” of sphingolipids that, unlike glycerolip-
ids, have head groups capable of being both hydrogen bond
donors and acceptors. This results in extensive lateral hy-
drogen bonding among sphingolipid head groups and much
higher melting temperatures (40–80
 
8
 
C), which make “sphin-
golipid islands” an ordered population at physiological tem-
peratures (1). These ordered fractions, known as lipid rafts,
are relatively detergent resistant and, besides sphingolipids,
contain cholesterol and a number of membrane-associated
glycophosphatidylinositol-linked and fatty-acylated proteins
(2, 3). Lipid rafts have been implicated in immune cell activa-
tion (4–10). Key signaling molecules associate with lipid rafts,
including protein tyrosine kinases (PTKs),
 
1
 
 heterotrimeric
and small G proteins, adaptor proteins, and phosphoinositides
(2–5). Cross-linking of surface receptors in hematopoietic
cells results in the enrichment of these receptors in the rafts
along with other downstream signaling molecules, such as
phospholipase C (PLC)
 
g
 
1, Vav, Zap70, and Syk (4, 6–9).
Furthermore, rafts redistribute to and cluster at the site of
TCR engagement when T cells are experimentally stimu-
lated with beads coated with anti-CD3 and anti-CD28 anti-
bodies (10). Based on these results, raft reorganization is pro-
posed to be associated with T cell costimulation, presumably
by recruiting signaling molecules and excluding phosphatases.
However, it remains unclear if raft redistribution is sim-
ply caused by a passive aggregation of cross-linked recep-
tors or if there is another level of regulation involved in raft
 
1
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redistribution. In this study, we evaluated the regulation of
raft redistribution during the development of cell-mediated
cytotoxicity. We used NK cells as a model because it has
been well characterized in NK cells that both positive and
negative signals critically regulate the development of cell-
mediated cytotoxicity. NK cells are CD16
 
1
 
CD56
 
1
 
TCR
 
2
 
sIg
 
2
 
lymphocytes capable of killing certain tumor cells or virus-
infected cells (“natural cytotoxicity”). Although receptors
involved in the activation of NK cells during natural cyto-
toxicity are still poorly defined, it is known that down-
stream signaling molecules include PTKs, as well as Rho
family low-molecular-mass G proteins, adaptor proteins,
and calcium (11–16).
NK cell activation is blocked when killer cell inhibitory
receptors (KIRs) on the surfaces of NK cells engage MHC
class I molecules on resistant target cells (11, 17–19). This
inhibition is mediated by KIR-associated SHP-1, a Src ho-
mology 2 (SH2) domain containing tyrosine phosphatase,
that dephosphorylates and inactivates signaling molecules
involved in NK cell activation (20–24). This well charac-
terized signaling model of NK cell activation enabled us to
evaluate a potential regulatory role for specific signaling
molecules in lipid raft reorganization. Furthermore, studies
of NK cell–mediated cytotoxicity allowed us to evaluate
lipid raft redistribution in a more physiological system in
which NK cells are activated by direct contact with target
cells. Using this experimental model, we have found that
raft reorganization during the development of cell-medi-
ated cytotoxicity depends on a balance between the posi-
tive and negative signals through opposing activities of
proximal PTKs and phosphatases. Our results imply that
raft polarization is a critical event during the development
of cell-mediated cytotoxicity, and inhibiting raft redistribu-
tion is a novel mechanism of negative regulation mediated
by inhibitory receptors.
 
Materials and Methods
 
Reagents, Cells, and Antibodies.
 
Unless otherwise indicated, all
chemicals were from Sigma Chemical Co. Human NK cells were
cloned and passaged as previously described (25). DX9
 
1
 
 
 
NK cell
clones were identified as previously described (15). The P815
murine mastocytoma cell line and the K562 human erythroid
leukemia cell line were obtained from American Type Culture
Collection. HLA class I–deficient 721 cells and HLA-B58 trans-
fected 721 cells were provided by Peter Parham (Stanford Uni-
versity, Palo Alto, CA). Anti-p70 KIR mAb DX9 was provided by
Lewis Lanier (DNAX Research Institute of Molecular and Cellu-
lar Biology, Palo Alto, CA). Piceatannol was obtained from Boeh-
ringer Mannheim. PP1 was obtained from BIOMOL Research
Labs., Inc. Herbimycin was obtained from GIBCO BRL.
 
Vaccinia Viruses.
 
Catalytically inactive SHP-C453S as well as
pSC65 vector control have been described (20). KIR3DL was
provided by Marcus Colonna (Basel Institute of Technology, Basel,
Switzerland). Wild-type Syk and SykT were provided by Jean-
Pierre Kinet and Andrew M. Scharenberg (Harvard Medical
School, Boston, MA) (26).
 
Cytotoxicity Assays.
 
The 
 
51
 
Cr-release assays measuring direct NK
cell–mediated cytotoxicity were performed as previously described
(25). Lytic units were calculated based on 20% cytotoxicity (27).
 
Raft Redistribution Assay.
 
NK cells were stained for 30–45 min
on ice with FITC–CTx (cholera toxin B subunit; 8 
 
m
 
g/ml). The
labeled cells were washed twice in PBS containing 0.2% BSA and
resuspended at a final concentration of 10
 
7
 
 cells/ml for NK cells
and 5 
 
3 
 
10
 
6
 
 cells/ml for target cells. Equal volumes (50 
 
m
 
l) of NK
cells and target cells were mixed, briefly pelleted, and then incu-
bated for 5 min at 37
 
8
 
C. The cells were then fixed and transferred
to glass slides by cytospin. NK cells that had formed conjugates
were assessed for raft redistribution using a fluoromicroscope (Carl
Zeiss, Inc.). A total of 50–100 conjugates was evaluated per slide,
and the evaluation was performed by an individual blinded to the
sample identities.
 
Results
 
Rafts Become Polarized during the Development of NK Cell–
mediated Cytotoxicity.
 
Natural cytotoxicity is initiated after
conjugate formation between an NK cell and a susceptible
target. We examined lipid raft reorganization that rapidly
ensues after this conjugate formation. As cholera toxin B
subunit (CTx) binds GM1 ganglioside (28), a marker of gly-
colipid-enriched rafts, human NK cells were stained with
FITC–CTx. After washing, NK cells were incubated with
hydroethidine-labeled target cells at 37
 
8
 
C, fixed, and spun
onto glass slides. Fig. 1 shows representative photographs
of NK cell–target cell conjugates. When incubated with
the NK-resistant cell line P815 (red), NK cell rafts (green)
are dispersed throughout the plasma membrane (Fig. 1 A).
In contrast, incubation of NK cells with the NK-sensitive
cell line K562 results in reorganization of lipid rafts into
“macrorafts” polarized at the area of contact with the sensi-
tive target (Fig. 1 B).
To quantify the difference in raft reorganization between
NK cells stimulated with sensitive (K562) versus resistant
(P815) cells, we evaluated NK–K562 and NK–P815 conju-
gates in three separate experiments (Fig. 2). For each experi-
ment, 100 conjugates were analyzed. The results are expressed
as the percentage of conjugates that have reorganized rafts.
As shown in Fig. 2, there is a marked difference between
sensitive and resistant cells in their ability to induce the for-
mation of macrorafts polarized toward the target. Less than
10% of NK cells in contact with resistant targets polarize
their rafts, whereas polarization is observed in close to 50%
of NK cells in contact with the sensitive target cells. Similar
results were obtained when another NK-sensitive cell line,
721, was used (data not shown).
 
Depletion of Cholesterol Inhibits Raft Polarization and NK
Cell Activation.
 
Cholesterol critically influences the stabil-
ity of lipid microdomains. Methyl-
 
b
 
-cyclodextrin (MCD)
depletes cholesterol from cell membranes and disrupts rafts
(29), which can then lead to inhibition of certain forms of
cellular activation (7, 29–31). To investigate the importance
of raft polarization on NK cell activation, NK cells were pre-
treated with MCD and then analyzed by confocal micros-
copy and cellular cytotoxicity assays. MCD treatment resulted
in the loss of evenly distributed rafts on unbound NK cells,
and polarized macrorafts could no longer be detected when 
349
 
Lou et al.
 
NK cells formed conjugates with sensitive tumor targets (e.g.,
K562; data not shown). The MCD treatment subsequently
blocked the generation of natural cytotoxicity (Fig. 3), sug-
gesting that raft polarization plays an important role in the de-
velopment of cell-mediated cytotoxicity.
 
Raft Polarization Requires Signaling by PTKs.
 
Several lines
of evidence suggest that rafts are important for lymphocyte
activation: most tyrosine-phosphorylated proteins and other
important second messengers have been found in lipid rafts
(4, 6–7), and pharmacological disruption of lipid rafts im-
pairs cellular activation (6, 7, 29–31). However, the mech-
anisms regulating raft redistribution have remained unclear.
We wanted to determine if raft polarization is dependent
on the activity of proximal tyrosine Src and Syk family ty-
rosine kinases. NK cells were preincubated with the Src kinase
inhibitors herbimycin A (32–34) or PP1 (35), or with the
Syk kinase inhibitor piceatannol (36). The IC
 
50 
 
for each
drug on Src or Syk PTK activities was first determined to
identify the appropriate concentration for each subsequent
experiment. Washed NK cells were then incubated with NK-
sensitive K562 cells. Raft polarization was quantified, and,
in parallel, the cytotoxic activity of NK cells treated with
the pharmacological inhibitors was measured. Fig. 4 shows
that preincubation of NK cells with either a Src or Syk
family PTK inhibitor blocks both raft polarization and cy-
totoxicity induced by K562 cells.
SykT is a catalytically inactive truncated mutant of Syk
kinase that can inhibit cytotoxicity when expressed in NK
cells (14). We transiently expressed SykT in NK cells using
recombinant vaccinia virus. The expression levels of the vi-
rus-encoded Syk T and wild-type Syk were equivalent to
the levels of endogenous Syk (data not shown). As shown
in Fig. 5, expression of SykT inhibits raft polarization and
Figure 1. Rafts polarize at the site of NK–target engagement upon stimulation with NK-sensitive target cells. FITC–CTx-labeled NK cells were incu-
bated at 378C for 5 min with hydroethidine-labeled P815 cells (A) or K562 cells (B), fixed, and spun onto glass slides. Images were recorded during con-
focal microscopy.
Figure 2. Comparison of raft
polarization of NK cells after stimu-
lation with NK-sensitive versus
NK-resistant target cells. FITC–
CTx-labeled NK cells were incu-
bated at 378C for 5 min with hy-
droethidine-labeled K562 cells or
P815 cells. NK cell–target cell con-
jugates were scored for raft polar-
ization by fluorescence microscopy.
100 conjugates were scored per
blinded sample. The three results
shown are representative of eight
total experiments.
Figure 3. Depletion of cholesterol blocks NK cell activation. NK cells
were pretreated with 10 mM MCD at 378C for 1 h, washed, and then in-
cubated for 4 h with 51Cr-labeled K562 cells. Results are expressed as
lytic units per 106 cells. 
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NK cell–mediated cytotoxicity when compared with ex-
pression of wild-type Syk or vector alone (PSC-65). There-
fore, experiments using either pharmacologic or genetic ap-
proaches suggest that raft polarization requires the activity
of proximal PTKs.
 
KIR Engagement Blocks Raft Reorganization.
 
NK activa-
tion is negatively regulated by MHC-recognizing KIRs.
However, the exact mechanism by which KIRs exert their
effect is still unclear. Negative signals mediated by KIRs
might block raft redistribution before polarized macrorafts
are formed. In this case, the blockade of raft redistribution
would prevent accumulation of downstream signaling mol-
ecules and inhibit signal amplification. Alternatively, nega-
tive regulators might accumulate in the macrorafts along
with key positive signaling molecules. To distinguish between
these two possibilities, we investigated the relationship be-
tween raft redistribution and KIR engagement. KIR3DL is a
KIR that is recognized by the mAb DX9 and recognizes the
serologically defined HLA-BW4 allotype (e.g., HLA-B58)
(37–39). DX9
 
1
 
 and DX9
 
2
 
 NK clones were isolated and then
incubated with either 721 cells or HLA-B58–transfected 721
cells (721-B58). The inhibitory effect of KIR engagement on
both raft redistribution and natural cytotoxicity is illustrated in
Fig. 6. Incubation of DX9
 
1
 
 NK cells with 721-B58 cells, but
not 721 cells, results in inhibition of raft redistribution and nat-
ural cytotoxicity. The raft redistribution and natural cytotoxic-
ity were not inhibited when DX9
 
2
 
 cells were incubated with
721-B58 cells, indicating that KIR engagement is responsible
for the inhibition of raft redistribution.
To further confirm that the inhibition of raft reorganiza-
tion is mediated by KIRs, we expressed KIR3DL by in-
fecting DX9
 
2
 
 NK cells with recombinant vaccinia virus
encoding KIR3DL. Nearly half of the NK cells exposed to
infectious recombinant virus expressed high levels of KIR3DL
as detected by flow cytometry (data not shown). As shown in
Fig. 7, expression of KIR3DL in DX9
 
2
 
 NK cells confers the
inhibitory effect on both raft redistribution and natural cyto-
toxicity when these NK cells encounter 721-B58 cells. NK
cells infected with control vaccinia virus (WR) were still able
to undergo raft redistribution and mediate the killing of 721-
B58 cells. These results are consistent with the notion that
the inhibitory effect of KIRs on cytotoxicity is mediated by
the blockade of raft redistribution.
 
Interrupting KIR–MHC Interactions Reverses the KIR-medi-
ated Blockade of Raft Redistribution.
 
KIR-mediated inhibi-
tion requires interaction between KIRs and specific MHC
class I molecules. Preincubation of KIR-expressing NK cells
with specific anti-KIR antibody reverses KIR-mediated in-
hibition of natural cytotoxicity by interrupting the interac-
tion between KIRs and their ligands (38, 39). To test
Figure 4. Inhibition of Src and Syk family kinases blocks raft redistri-
bution. Left panels: NK cells were pretreated with 2 mM herbimycin A or
DMSO at 378C for 16 h or with DMSO, 10 mM PP1, or 25 mg/ml
piceatannol at 378C for 20 min, labeled with FITC–CTx, and incubated
with hydroethidine-labeled K562 cells. NK–target conjugates were
scored for raft polarization. The results are expressed as percentage of
control. Right panels: NK cells pretreated with drugs as above were incu-
bated with 51Cr-labeled K562 for 4 h. Lytic units per 106 cells were mea-
sured, and the results are expressed as percentage of control. The two re-
sults shown are representative of five total experiments.
Figure 5. Expression of dominant negative, catalytically inactive Syk
inhibits raft redistribution. Left panels: NK cells were infected for 4 h at a
multiplicity of infection of 20 with control recombinant vaccinia viruses
(PSC-65) or recombinant vaccinia encoding either wild-type Syk or cata-
lytically inactive, truncated Syk (Syk T). Infected NK cells were stained
with FITC–CTx and incubated with hydroethidine-labeled K562. NK–
target conjugates were scored for raft redistribution. Right panels: in-
fected NK cells were incubated with 51Cr-labeled K562 cells for 4 h. The
two results shown are representative of five total experiments.
Figure 6. KIR engagement blocks raft redistribution. Left panel:
FITC–CTx-stained DX91 or DX92 NK cells were incubated with 721
cells or with HLA-B58–transfected 721 cells (721-B58) and scored for raft
redistribution. The results are expressed as the percentage of conjugates
with polarized rafts. Right panel: DX91 or DX92 NK clones were incu-
bated for 4 h with 51Cr-labeled K562 cells. The results were expressed as
lytic units per 106 cells. The results shown are representative of three dif-
ferent experiments. 
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whether interrupting the KIR3DL–HLA-B58 interaction
would also reverse the blockade of raft redistribution, we pre-
incubated DX9
 
1
 
 or DX9
 
2
 
 NK cells with DX9 mAb on ice
for 5 min before incubating them with 721 or 721-B58 cells.
Preincubation of DX9
 
1
 
 cells with DX9 mAb completely re-
versed the inhibitory effect of KIR engagement on both raft
reorganization (Fig. 8) and natural cytotoxicity (data not
shown), whereas there was little effect on DX9
 
2
 
 cells. These
results confirm that KIR–MHC interaction is necessary for
the inhibitory effect on raft redistribution.
 
SHP-1 Activity Is Necessary for the KIR-mediated Blockade
of Raft Redistribution.
 
KIR-mediated inhibition depends
on the protein tyrosine phosphatase SHP-1. Previous stud-
ies have demonstrated that overexpression of the dominant
negative SHP-1 (SHPC453S), which is catalytically inac-
tive, reverses the KIR-mediated inhibitory effect on natural
cytotoxicity and antibody-dependent cellular cytotoxicity
(20, 21). To test if the blockade of raft reorganization also de-
pends on SHP-1, we expressed SHPC453S or the wild-type
SHP-1 in DX9
 
1
 
 cells. In these experiments, the expression
levels of the virus-encoded SHP-C453S and SHP-1 were
equivalent to that of endogenous SHP-1 (data not shown).
Expression of the dominant negative (Fig. 9) but not the
wild-type SHP-1 (data not shown) reversed the KIR-medi-
ated blockade of raft redistribution, indicating that KIR-
mediated inhibition of raft redistribution depends on SHP-1.
 
Discussion
 
Cellular activation is a result of multiple enzyme–sub-
strate reactions that amplify, diversify, and regulate signals
initiated from surface receptors. Most of these reactions oc-
cur at the plasma membrane, where signaling molecules
cluster in a multimolecular complex around surface recep-
tors. This clustering enables compartmentalization of key
second messengers and results in the amplification of signal
transduction cascades. Rafts can act as platforms holding sig-
naling molecules together (4, 6, 7). This was recently high-
lighted by the demonstration that rafts redistribute to and
cluster at the site of TCR engagement when T cells are
stimulated with bead-coupled antibodies (10). The redistri-
bution and clustering of rafts leads to higher and more sta-
Figure 7. Expression of KIR3DL in DX92 NK clones confers an in-
hibitory effect on raft redistribution. DX92 NK cells were infected for 4 h
at a multiplicity of infection of 20 with either recombinant vaccinia virus
encoding KIR3DL or wild-type vaccinia virus (WR). Left panels: in-
fected NK cells were stained with FITC–CTx and incubated with 721-
B58 cells or parental 721 cells and scored for raft redistribution. Right
panels: infected NK cells were incubated with 51Cr-labeled 721-B58 cells
or 721 cells. Lytic units per 106 cells were measured. The two results
shown are representative of six total experiments.
Figure 8. Interruption of KIR–MHC interactions reverses KIR-medi-
ated blockade of raft redistribution. (A) DX91 or DX92 NK cells stained
with FITC–CTx were preincubated with 10 mg/ml DX9 antibody on ice
for 5 min or left untreated. The cells were then incubated with hydroethi-
dine-labeled 721-B58 cells or 721 cells and scored for raft redistribution.
The two results shown are representative of three different experiments.
Figure 9. Expression of dominant negative SHP-1 reverses KIR-medi-
ated inhibition of raft redistribution. DX91 or DX92 NK cells were in-
fected for 4 h at a multiplicity of infection of 20 with control recombi-
nant vaccinia virus (PSC-65) or dominant negative, catalytically inactive
SHP-1 (SHPC453S). Infected NK cells were stained with FITC–CTx,
incubated with hydroethidine-labeled 721-B58 cells or 721 cells, and
then scored for raft redistribution. The two results shown are representa-
tive of four different experiments. 
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ble tyrosine phosphorylation of signaling molecules, pre-
sumably by recruiting key signaling molecules and excluding
phosphatases. However, due to the high concentration of an-
tibodies bound on the beads, the redistribution of rafts
could be caused by physical forces, so it remains unanswered
whether or not raft redistribution is a regulated process. In
this paper, we have studied raft redistribution using NK
cells that are directly stimulated by viable target cells. We
show that rafts become aggregated and polarized at the site
of contact between NK cells and sensitive target cells. The
detection of raft redistribution in this physiological system
implies that raft redistribution is a regulated process.
The functional role of rafts during lymphocyte activation
has been evaluated in several studies. The absence of de-
tectable 
 
z
 
 and PLC
 
g
 
1 tyrosine phosphorylation and dimin-
ished calcium signals upon pharmacological disruption of
rafts was interpreted as evidence for temporal order of events
in which raft formation and polarization precedes activa-
tion of signal transduction cascade (6, 7, 29–31, 40). This
view is supported by the observation that even cross-link-
ing of glycophosphatidylinositol-linked peripheral membrane
proteins can stimulate T cells, presumably through an in-
creased local concentration of key signal transducing mole-
cules (40–43). However, our data suggest that the polariza-
tion of lipid rafts is signaling dependent. Inhibition of the
activity of Src or Syk family PTKs blocks reorganization of
lipid rafts. Moreover, inhibitory signals initiated by KIR
engagement also block raft polarization in an SHP-1–depen-
dent manner. Because regulatory second messengers accu-
mulate in rafts, and, at the same time, raft polarization de-
pends on activation signals, it is likely that there is a positive
feedback loop between raft aggregation and positive signal
propagation. Instead of a unidirectional sequence of events
(receptor cross-linking
 
®
 
raft aggregation
 
®
 
signal transduc-
tion), we believe that these three processes are interdepen-
dent. Lateral bonding between sphingolipids within rafts in-
creases spatial rigidity of the receptor–ligand interactions.
These rigid receptor–ligand interactions might then keep
the signaling complex together for a longer time, which in
turn might aggregate more sphingolipid-associated proteins
into the cellular interphase and increase the probability of a
complete cellular activation. Consistent with this notion, the
interaction between cytoskeleton and lipid rafts has been
proposed to increase raft stability (40), and a recent study
suggests that the interaction between cytoskeleton and lipid
rafts depends on tyrosine kinase activity (44). Furthermore,
rafts are proposed to act as transporters of surface receptors
and key signaling molecules during the formation of immu-
nological synapses (10, 45–47). This process has been shown
to be driven by the movement of cytoskeleton and depen-
dent on signal transduction (48).
KIRs block the activation of NK cells through SHP-
1–mediated dephosphorylation of molecules involved in the
activation cascade (20–23). Several direct targets of SHP-1
have been proposed (15, 24), but none of the current models
have been able to fully explain the sequence of events during
inhibitory signaling. Our data suggest that the negative sig-
nals mediated by KIRs arise during the earliest phase of NK
activation, specifically before the formation of “macrorafts.”
Presumably, KIR-associated SHP-1 dephosphorylates and
inactivates key signaling molecules that are required for the
signal cascade leading to raft aggregation. On the other
hand, aggregation of lipid rafts helps exclude phosphatase
activity from the sites of positive signal propagation (10,
49). In our biochemical assays, neither KIRs nor SHP-1
could be detected in rafts (Jevermovic, D., Z. Lou, and P.J.
Leibson, unpublished observation). Overall, the efficacy of
raft redistribution and aggregation would ultimately be a
function of the balance between positive and negative sig-
nals generated after interaction with specific target cells.
Our study provides new insights as to the regulatory
events that critically influence the development of cell-
mediated cytotoxicity. Lipid raft redistribution and polar-
ization is regulated by positive and negative signals from the
membrane receptors, and the integration of these signals
can ultimately determine the commitment of cytotoxic
lymphocytes to cellular cytotoxicity. This study also dis-
closes a novel inhibitory mechanism that has the potential
to be employed by certain homologous inhibitory recep-
tors expressed on cells of both hematopoietic and nonhe-
matopoietic lineages.
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